Cellmid Limited (ASX:CDY)

5.6¢

right-arrow Created with Sketch. 0 (0%)
MCAP $12.33M
Last trade 14.00pm 09/12/2021 20mins delayed

Latest Announcements

09/12/2021CDYCellmid Limited
09/12/2021CDYCellmid Limited
07/12/2021CDYCellmid Limited
10/11/2021CDYCellmid Limited
09/11/2021CDYCellmid Limited
09/11/2021CDYCellmid Limited
09/11/2021CDYCellmid Limited
08/11/2021CDYCellmid Limited

Company Overview

Cellmid Limited is an Australia-based health and beauty-tech business company. The Company is specialized in developing anti-aging solutions. The Company operates through two segments: Diagnostics and Consumer Health. The Company is engaged in the research and development of diagnostic and therapeutic products for the management of diseases, such as cancer and various chronic inflammatory conditions by targeting midkine. It is also engaged in the development and sale of over the counter (OTC) and cosmetic products for hair loss and anti-aging hair care through its FGF5 inhibitor technology. It has developed a range of products under the evolis, evolis Professional, Lexilis Hybrid, Jo-JuRED and Lexilis BLACK brands.

CDY in the news

Cellmid (CDY) acquires BLC Cosmetics from HLG Limited (HNG)The company has today…
Cellmid (CDY) pens a deal to acquire BLC Cosmetics through a share…
Cellmid (CDY) closes slightly higher following the release of its latest quarterly…
Anti-ageing product maker Cellmid (CDY) trades higher after announcing record revenue from…

Search Previous Announcements